Tanvex BioPharma USA, Inc. announced the resignation of Dr. Yun Yen as Chairman/President. Resume of the previous position holder: Tanvex Biopharma, Inc. Chairman/CEO. Effective date is December 29, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39 TWD | +1.17% | -1.39% | -40.09% |
May. 28 | Tanvex BioPharma, Inc.(TWSE:6541) dropped from S&P Global BMI Index | CI |
Mar. 14 | Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-40.09% | 199M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-0.26% | 21.83B | |
-10.32% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- 6541 Stock
- News Tanvex BioPharma, Inc.
- Tanvex BioPharma, Inc. Announces Resignation of Yun Yen as Chairman/President, Effective December 29, 2023